What are biosimilars?

Biosimilars are biotechnology drugs that are equivalent – in terms of quality, efficiency and safety – to a reference product that has previously been licenced.

Just like the original products, they are created from a biological substance (a hormone, protein, natural enzyme or monoclonal antibody) that can be used for either all the indications of the reference drug.

In this way, mAbxience’s biosimilars are helping to facilitate greater accessibility to therapies that, prior to the release of these biosimilars, would have been prohibitively expensive for national health services.

What I need to know about Biosimilar Medicines. Information for patients